首页> 外国专利> METHOD FOR PREDICTING THE ANTIARRHYTHMIC EFFECTIVENESS OF A MYOCARDIAL REVASCULARISATION OPERATION IN PATIENTS WITH ISCHEMIC HEART DISEASE WITH VENTRICULAR ARRHYTHMIAS PROVOKED BY MYOCARDIAL ISCHEMIA

METHOD FOR PREDICTING THE ANTIARRHYTHMIC EFFECTIVENESS OF A MYOCARDIAL REVASCULARISATION OPERATION IN PATIENTS WITH ISCHEMIC HEART DISEASE WITH VENTRICULAR ARRHYTHMIAS PROVOKED BY MYOCARDIAL ISCHEMIA

机译:用心肌缺血激发缺血性心脏病患者心肌血型血管异常手术的抗心律失常效果的方法,心肌缺血引发

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to cardiology. At the preoperative stage, topical diagnostics of the focus of arrhythmia is performed, wherefor recording electrodes are attached to the surface of the chest of the patient to conduct surface non-invasive electrophysiological cardiac mapping (NEPCM) and an exercise tolerance test (ETT) is performed, followed by transferring the patient to a horizontal position when the criteria for a positive ETT test are reached, while recording a multi-channel ECG from the surface of the torso of the patient, and continuing to record the multi-channel ECG for the duration of the recovery period. A CT or MRI of the chest of the patient is performed with attached electrodes, the results of the ECG, CT or MRI of the chest are processed. The location of the focus of arrhythmia recorded against the ETT test is determined and compared to the blood supply area of the coronary artery (CA) with hemodynamically significant stenosis, obtained based on the results of coronary angiography (CAG), and if the localisation of the focus of arrhythmogenesis matches the blood supply area of the CA with hemodynamically significant stenosis, antiarrhythmic (AA) effectiveness of the myocardial revascularisation (MR) operation is predicted. If the location of the focus of arrhythmogenesis does not match the blood supply area of the CA with hemodynamically significant stenosis, the absence of AA effectiveness of the operation is predicted.;EFFECT: provides a possibility of predicting the AA effectiveness of the MR operation at the preoperative stage, selecting the proper procedure for managing IHD patients with VAs associated with myocardial ischemia, and also identifying the CA, located in the blood supply area whereof is the focus of the VA, the blood flow wherein needs to be restored at the operative stage.;1 cl, 3 ex
机译:田地:医学。物质:发明涉及医学,即心脏病学。在术前阶段,进行心律失常焦点的局部诊断,将记录电极连接到患者胸部的表面以进行表面无侵入电生理心脏测绘(Nepcm)和运动耐受性测试(ETT)是当达到正面ETT测试的标准时,在达到患者的标准时进行,然后将患者转移到水平位置,同时从患者的躯干表面记录多通道ECG,并继续记录多通道ECG恢复期的持续时间。用附接电极进行患者胸部的CT或MRI,加工胸部的ECG,CT或MRI的结果。记录对ETT试验的心律失常的焦点的位置,并与冠状动脉(CA)的血液供应区域进行血流动力学显着的狭窄,基于冠状动脉造影(CAG)的结果获得,如果定位心律发生的焦点与血流动力学显着的狭窄的Ca的血液供应区域与血液动力学显着的狭窄,预测心肌血型血管体外(MR)操作的抗心律失常(AA)有效性。如果心律失常的焦点的位置与血流动力学上显着的狭窄的血液供应区域与血流动力学显着的狭窄不匹配,则预测操作的效果。;效果:提供预测MR操作的AA效能的可能性术前阶段,选择用于管理与心肌缺血相关的VAS的IHD患者的适当程序,以及识别位于血液供应区域中的CA,其中是VA的焦点,其中需要在手术中恢复的血流阶段。; 1 cl,3前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号